Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of TRML will rise by +0.28% over the next 2 Weeks and hit $48.11 by Monday, November 10, 2025. In that time frame, TRML's share price is expected to range between $46.01 and $50.47.
BearishAverageBullishTRML shares remained flat 0 in Tuesday, October 28, 2025's trading session, starting and closing at a previous close of $47.98 to move at $47.98. The stock demonstrated notable intraday movement (see TRML's key stats for a full breakdown), fluctuating between $47.98 and $47.98, a 0 trading range. While recent weeks have seen some volatility, TRML has managed to secure a +0.21% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 783.7K shares changing hands, 154.92K more than the previous session. This amounted to $37.60M in total market activity.
Will TRML Continue Its Upward Trend?
According to analyst ratings and projections for TRML, Tourmaline Bio, Inc. shares are anticipated to increase by +4.74%, potentially reaching $50.37 per share by November 10, 2025. Short-term technical indicators currently suggest a neutral sentiment for TRML. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the TRML stock forecast, now is a good time to buy TRML stock because its current trading price is -0.28% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on TRML covering social and institutional perspectives.
TRML Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into TRML's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 85.92% to 89.34%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 79.39%, indicates significant medium-term strength. However, the 100-day RSI, at 68.55%, points to growing bullish momentum over the long term. Insights into TRML's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Tourmaline Bio Short-Term Forecasts
TRML Forecast For Next 5 Days
Our algorithm anticipates Tourmaline Bio (TRML) stock could hit $49.98 by Nov 21, 2025. This represents a +4.17% rise from today's price, following a +0.10% change over the past five days.
TRML Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Tourmaline Bio, Inc. (TRML) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $48.02, which would mean a +0.08% increase from the current price of $47.98. Projections for this period range from a high of $57.66 to a low of $37.71.
TRML Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Tourmaline Bio's price over the next three months point to a drop. TRML stock is expected to peak at $31.24 on Mar 17, 2026 after potentially dipping to $18.74 on Jan 06, 2026. On average, TRML is likely to trade around $24.69 in the coming 90 days.
Tourmaline Bio Stock Forecast 2025
Based on our predictive models, Tourmaline Bio (TRML) is expected to trade between $13.89 and $27.10 throughout 2025. This would result in an average price of $20.94, potentially offering investors a -56.36% return from current levels.
Tourmaline Bio, Inc. Monthly Forecast 2025–2026
November 2025
According to our latest forecast models, Tourmaline Bio, Inc. (TRML) is positioned to show a strong performance in November 2025. The price is predicted to move between $13.89 and $27.10, settling at an average of $19.93. This could translate to a -58.46% loss.
December 2025
Based on current market signals, Tourmaline Bio, Inc. is projected to trend december 2025. We forecast a trading range from $16.30 to $27.10, with a likely average price of $21.77. Investors could expect a potential return of -54.63%.
January 2026
Our predictive algorithms indicate Tourmaline Bio, Inc. stock may see a shift in January 2026. The expected range spans $18.74–$27.46, with an average target of $22.95. This represents a cautious outlook and a possible loss of -52.17%.
February 2026
Analyzing established trends, Tourmaline Bio, Inc. looks set to move in February 2026. Projections place the stock between $19.87 and $29.77, averaging around $25.51. This suggests a -46.83% loss from current levels.
March 2026
Market indicators suggest Tourmaline Bio, Inc. could experience notable changes during March 2026. Prices could fluctuate within $20.67 to $31.24, with a midpoint forecast of $26.32. The stock might deliver a -45.14% loss.
April 2026
Forecasting for April 2026, models estimate that Tourmaline Bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $14.54 and $27.68, averaging $20.39. This signals a cautious trajectory with potential returns around -57.50%.
May 2026
According to our latest forecast models, Tourmaline Bio, Inc. (TRML) is positioned to show a strong performance in May 2026. The price is predicted to move between $16.97 and $27.33, settling at an average of $22.09. This could translate to a -53.96% loss.
June 2026
Based on current market signals, Tourmaline Bio, Inc. is projected to trend june 2026. We forecast a trading range from $18.75 to $27.58, with a likely average price of $23.10. Investors could expect a potential return of -51.85%.
July 2026
Our predictive algorithms indicate Tourmaline Bio, Inc. stock may see a shift in July 2026. The expected range spans $20.39–$30.45, with an average target of $25.79. This represents a cautious outlook and a possible loss of -46.25%.
August 2026
Analyzing established trends, Tourmaline Bio, Inc. looks set to move in August 2026. Projections place the stock between $20.73 and $31.62, averaging around $26.22. This suggests a -45.35% loss from current levels.
September 2026
Market indicators suggest Tourmaline Bio, Inc. could experience notable changes during September 2026. Prices could fluctuate within $14.72 to $27.81, with a midpoint forecast of $20.24. The stock might deliver a -57.82% loss.
October 2026
Forecasting for October 2026, models estimate that Tourmaline Bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $17.59 and $32.60, averaging $22.78. This signals a cautious trajectory with potential returns around -52.52%.
TRML's history of dividends and stock splits also plays a role in long-term investor confidence.

